It is time to rethink physicians’ approach to keratoconus

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.Earlier this year, the FDA approved corneal collagen cross-linking for the treatment of keratoconus and corneal ectasia. In this issue, I will discuss how this may affect the way we approach keratoconus patients in the future. I hope you enjoy the discussion.